GREENWICH LIFESCIENCES INC (GLSI) Stock Income Statement
USA - NASDAQ:GLSI - US3968791083 - Common Stock
8.32 USD
+0.12 (+1.46%)
8.32 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 18.14M | 16.01M | 9.33M | 8.04M | 4.60M | |||
| Research and Development | 14.56M | 12.95M | 7.70M | 6.48M | 3.56M | |||
| Selling, General, and Administrative Expenses | 3.58M | 3.06M | 1.63M | 1.56M | 1.04M | |||
| Operating Income | -18.14M | -16.01M | -9.33M | -8.04M | -4.60M | |||
| Interest Income/Expense | 148.90K | 223.00K | 436.10K | 220.00K | 30.00K | |||
| Other Income/Expense | null | null | null | null | null | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | -17.99M | -15.79M | -8.89M | -7.83M | -4.57M | |||
| Income Tax | null | null | null | null | null | |||
| Net Income | -17.99M | -15.79M | -8.89M | -7.83M | -4.57M | |||
| EBITDA | -18.14M | -16.01M | -9.32M | undefined | undefined | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.3631000000000002 | -1.2132 | -0.6921 | -0.61 | -0.35 | |||
| Non GAAP EPS | -1.36 | -1.2 | null | -0.61 | null | |||
| Statistics | ||||||||
All data in USD